Soreide K, Ismail W, Roalso M, Ghotbi J, Zaharia C
Cancer Control. 2023; 30:10732748231154711.
PMID: 36916724
PMC: 9893084.
DOI: 10.1177/10732748231154711.
Zhang X, Qin X, Yu T, Wang K, Chen Y, Xing Q
Front Genet. 2022; 13:974726.
PMID: 36338996
PMC: 9630733.
DOI: 10.3389/fgene.2022.974726.
Wang X, Wu Y, Zhang Y, Ke J, Wang Z, Zhang B
Diabetol Metab Syndr. 2022; 14(1):10.
PMID: 35033179
PMC: 8761339.
DOI: 10.1186/s13098-022-00783-3.
Hao J, Yuan B, Gou Y, Ma J, Huang X
Dis Markers. 2021; 2021:5595965.
PMID: 34900027
PMC: 8660201.
DOI: 10.1155/2021/5595965.
Li Y, Huo J, He J, Ma X
Cancer Cell Int. 2021; 21(1):331.
PMID: 34193130
PMC: 8243592.
DOI: 10.1186/s12935-021-01911-1.
Decoding LncRNAs.
Borkiewicz L, Kalafut J, Dudziak K, Przybyszewska-Podstawka A, Telejko I
Cancers (Basel). 2021; 13(11).
PMID: 34072257
PMC: 8199187.
DOI: 10.3390/cancers13112643.
Target Enrichment Enables the Discovery of lncRNAs with Somatic Mutations or Altered Expression in Paraffin-Embedded Colorectal Cancer Samples.
Iraola-Guzman S, Brunet-Vega A, Pegueroles C, Saus E, Hovhannisyan H, Casalots A
Cancers (Basel). 2020; 12(10).
PMID: 33019720
PMC: 7650602.
DOI: 10.3390/cancers12102844.
Research progress regarding the role of long non-coding RNAs in osteosarcoma.
Zhang Y, Pu Y, Wang J, Li Z, Wang H
Oncol Lett. 2020; 20(3):2606-2612.
PMID: 32782578
PMC: 7400499.
DOI: 10.3892/ol.2020.11807.
Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysis.
Zhu H, Zhao S, Jiao R, Wang H, Tang R, Wu X
Cancer Cell Int. 2020; 20:304.
PMID: 32675944
PMC: 7353815.
DOI: 10.1186/s12935-020-01403-8.
Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression.
Lin K, Chen H, Su C, Zhu H, Lai C, Shi Y
Cancer Manag Res. 2020; 12:3091-3097.
PMID: 32440207
PMC: 7210020.
DOI: 10.2147/CMAR.S249456.
The Translational Potential of Electrochemical DNA-Based Liquid Biopsy.
Miranda-Castro R, Palchetti I, de-Los-Santos-Alvarez N
Front Chem. 2020; 8:143.
PMID: 32266206
PMC: 7099045.
DOI: 10.3389/fchem.2020.00143.
Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients.
Xiao H, Ding N, Liao H, Yao Z, Cheng X, Zhang J
Medicine (Baltimore). 2019; 98(45):e17583.
PMID: 31702614
PMC: 6855493.
DOI: 10.1097/MD.0000000000017583.
Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma.
Yang B, Shen J, Xu L, Chen Y, Che X, Qu X
Front Oncol. 2019; 9:898.
PMID: 31620361
PMC: 6759597.
DOI: 10.3389/fonc.2019.00898.
Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression.
Zhang H, Wei P, Lv W, Han X, Yang J, Qin S
Cell Biosci. 2019; 9:81.
PMID: 31592114
PMC: 6775667.
DOI: 10.1186/s13578-019-0345-4.
Up-regulation of activates expression by competitive binding to miR-139-5p to promote hepatocellular carcinoma progression.
Wu G, Ju X, Wang Y, Li Z, Gan X
Cell Cycle. 2019; 18(16):1849-1867.
PMID: 31258024
PMC: 6681790.
DOI: 10.1080/15384101.2019.1629772.
LncRNA TUBA4B functions as a competitive endogenous RNA to inhibit gastric cancer progression by elevating PTEN via sponging miR-214 and miR-216a/b.
Guo J, Li Y, Duan H, Yuan L
Cancer Cell Int. 2019; 19:156.
PMID: 31198405
PMC: 6556040.
DOI: 10.1186/s12935-019-0879-x.
The Role of Non-Coding RNA in Congenital Heart Diseases.
Duenas A, Exposito A, Aranega A, Franco D
J Cardiovasc Dev Dis. 2019; 6(2).
PMID: 30939839
PMC: 6616598.
DOI: 10.3390/jcdd6020015.